The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the United States that needs to be addressed by the oncology community, according to a commentary published in the Journal of the National Cancer Institute.
Full article >>
Tuesday, June 30, 2009
How Much Is Life Worth? The $440 Billion Question
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment